Ambry Genetics Sues Myriad Genetics for Violating Federal Antitrust Laws

Ambry Genetics has filed a counterclaim against Myriad Genetics in response to the latter’s patent infringement suit filed against Ambry in July. Ambry is claiming that Myriad is yet again engaging in anticompetitive behavior, a trend that landed Myriad in front of the Supreme Court facing accusations by more than 30 organizations in April.
Yahoo! Finance